Back to Search Start Over

Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.

Authors :
Wood MR
Schirripa KM
Kim JJ
Wan BL
Murphy KL
Ransom RW
Chang RS
Tang C
Prueksaritanont T
Detwiler TJ
Hettrick LA
Landis ER
Leonard YM
Krueger JA
Lewis SD
Pettibone DJ
Freidinger RM
Bock MG
Source :
Journal of medicinal chemistry [J Med Chem] 2006 Feb 23; Vol. 49 (4), pp. 1231-4.
Publication Year :
2006

Abstract

Antagonism of the bradykinin B1 receptor represents a potential treatment for chronic pain and inflammation. Novel antagonists were designed that display low-nanomolar affinity for the human bradykinin B1 receptor and good bioavailability in the rat.

Details

Language :
English
ISSN :
0022-2623
Volume :
49
Issue :
4
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
16480259
Full Text :
https://doi.org/10.1021/jm0511280